Primary Site >> Colorectal Cancer
Gene >> LASP1
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Comparative proteomic analysis identifies proteins associated with the development and progression of colorectal carcinoma. PMID: 20812987 |
Ref: Proteogenomic analysis of human colon carcinoma cell lines LIM1215, LIM1899, and LIM2405. PMID: 23458625 Ref: miR-133a represses tumour growth and metastasis in colorectal cancer by targeting LIM and SH3 protein 1 and inhibiting the MAPK pathway. PMID: 23968734 |
Ref: The clinicopathological significance of miR-133a in colorectal cancer. PMID: 25104873 Ref: Tumor suppressor miR-1 restrains epithelial-mesenchymal transition and metastasis of colorectal carcinoma via the MAPK and PI3K/AKT pathway. PMID: 25196260 Ref: LIM and SH3 protein 1 induces TGFbeta-mediated epithelial-mesenchymal transition in human colorectal cancer by regulating S100A4 expression. PMID: 25252758 |
Ref: Loss of the 14-3-3sigma is essential for LASP1-mediated colorectal cancer progression via activating PI3K/AKT signaling pathway. PMID: 27156963 Ref: LASP1-S100A11 axis promotes colorectal cancer aggressiveness by modulating TGFbeta/Smad signaling. PMID: 27181092 Ref: Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1. PMID: 27626692 |
Ref: LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition. PMID: 28606091 |
Ref: COPS5 and LASP1 synergistically interact to downregulate 14-3-3sigma expression and promote colorectal cancer progression via activating PI3K/AKT pathway. PMID: 29226323 |